Cancer medicines
Palbociclib
Palbociclib
A CDK4/6-targeted therapy used with endocrine treatment.
Sources checked · Introductory guide
On this page
How it works
It inhibits cell-cycle regulators CDK4 and CDK6 to slow growth.[3]
Where it is used
Used with an aromatase inhibitor or fulvestrant in selected HR-positive, HER2-negative advanced breast cancers.[1]
Key safety points
Blood counts need monitoring. Report fever, chills, new cough or breathlessness immediately and follow the prescribed dosing and break schedule.[2]
Questions for your care team
- What endocrine therapy, blood tests and treatment breaks are planned?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Palbociclib (opens in a new tab)
- MedlinePlus · Palbociclib (opens in a new tab)
- NCI Drug Dictionary · Palbociclib (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.